- Theravance-GSK's COPD drug wins support of FDA panel
A panel of FDA advisers endorsed the approval of GlaxoSmithKline and Theravance's Breo Ellipta as a treatment for chronic obstructive pulmonary disease. The once-daily inhaled treatment, a combination of fluticasone furoate and vilanterol, would compete with GSK's Advair and AstraZeneca's Symbicort. The FDA could issue a decision by May 12. Reuters (4/17), Bloomberg Businessweek (4/17)        | Xcellerate® Clinical Trial Optimization®
When a large multinational client asked Covance to conduct a Phase III trial on a promising new colorectal cancer drug, their rigorous patient selection criteria initially caused some concern. How long would it take to identify, recruit and retain sufficient qualifying patients? To learn how Covance delivered the study ahead of schedule, click here. | |
| Health Care & Policy |  |  | | - Stem cells from bone marrow do well in Mayo heart failure trial
Heart function improved for all patients who received autologous, bone marrow-derived stem cells in a trial conducted by the Mayo Clinic's Center for Regenerative Medicine in Minnesota, according to a study in the Journal of the American College of Cardiology. The stem cells were modified to act as cardiac cells before being injected into the patients, who were being treated for heart failure. Daily Express (London) (4/12)  | Two courses in four days at MIT Sloan Exec Ed
Learn from world-renowned faculty at MIT Executive Education and make the most of your visit with back-to-back two-day courses. Understand big data, revitalize your digital business model, solve complex business problems, drive strategic innovation.
View 25+ short courses. |
 | Industry Deals | | | | | Food & Agriculture | | | | | Industrial & Environmental | | | | - International Energy Agency: More biofuel needed to fight warming
The world is lagging behind the goal of limiting the increase in global temperatures by 2020 to 2 degrees Celsius, according to a new report by the International Energy Agency. To make up for lost time, the agency recommends at least doubling biofuel production annually while raising advanced biofuel capacity sixfold through targeted government support and other measures. "We agree with the IEA that biofuels offer real GHG emissions reductions today and that we must increase biofuel usage if we want to mitigate the impacts of climate change," said Bliss Baker, spokesman for the Global Renewable Fuels Alliance. DomesticFuel.com (4/17)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| News from BIO | | | | - Win an Apple TV, $100 Visa gift card, Keurig coffee system ...
... and other valuable prizes at the BIO International Convention, April 22-25 in Chicago. Try your luck at the raffle at the BIO Partner Pavilion, Booth No. 3651, where you can win great prizes as well as learn how your company can save money through the BIO Business Solutions cost-savings program. Visit Booth #3651 to collect your raffle card, then follow the instructions to be eligible for the raffle drawing. And return from the Convention with ways to save your company money on products and services through the BIO Business Solutions program.
| SmartQuote | | | |  | To dare is to lose one's footing momentarily. To not dare is to lose oneself."
--Søren Kierkegaard,
Danish philosopher and writer  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Wednesday, April 17, 2013
- Tuesday, April 16, 2013
- Monday, April 15, 2013
- Friday, April 12, 2013
- Thursday, April 11, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment